JNJ(JNJ)
JNJ
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $100.93B | $107.79B | $115.25B | $122.35B | $133.03B |
| Low | $100.73B | $104.65B | $115.04B | $120.49B | $131.01B |
| High | $101.18B | $109.40B | $115.46B | $124.19B | $135.04B |
| EBITDA Avg | $33.53B | $35.81B | $38.29B | $40.64B | $44.19B |
| Low | $33.46B | $34.77B | $38.22B | $40.03B | $43.52B |
| High | $33.61B | $36.34B | $38.36B | $41.26B | $44.86B |
| EBIT Avg | $24.83B | $26.51B | $28.35B | $30.09B | $32.72B |
| Low | $24.78B | $25.74B | $28.30B | $29.64B | $32.23B |
| High | $24.89B | $26.91B | $28.40B | $30.55B | $33.22B |
| Net Income Avg | $28.28B | $31.37B | $32.52B | $37.86B | $42.55B |
| Low | $27.83B | $29.65B | $26.20B | $37.12B | $41.71B |
| High | $28.73B | $33.09B | $38.85B | $38.61B | $43.39B |
| EPS Avg | $11.57 | $12.75 | $14.01 | $15.59 | $17.52 |
| Low | $11.45 | $12.21 | $10.78 | $15.28 | $17.17 |
| High | $11.83 | $13.62 | $15.99 | $15.89 | $17.86 |
| Analysts (Rev / EPS) | 17 / 13 | 18 / 13 | 17 / 5 | 11 / 2 | 15 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $24.98B | $25.27B | $26.59B | $25.13B | $26.26B | $26.96B | $28.75B | $26.19B |
| Low | $24.57B | $24.99B | $26.28B | $24.84B | $25.95B | $26.64B | $28.41B | $25.89B |
| High | $25.30B | $25.61B | $26.99B | $25.50B | $26.65B | $27.36B | $29.18B | $26.58B |
| EBITDA Avg | $8.30B | $8.40B | $8.83B | $8.35B | $8.72B | $8.96B | $9.55B | $8.70B |
| Low | $8.16B | $8.30B | $8.73B | $8.25B | $8.62B | $8.85B | $9.44B | $8.60B |
| High | $8.41B | $8.51B | $8.96B | $8.47B | $8.85B | $9.09B | $9.69B | $8.83B |
| EBIT Avg | $6.14B | $6.22B | $6.54B | $6.18B | $6.46B | $6.63B | $7.07B | $6.44B |
| Low | $6.04B | $6.15B | $6.46B | $6.11B | $6.38B | $6.55B | $6.99B | $6.37B |
| High | $6.22B | $6.30B | $6.64B | $6.27B | $6.55B | $6.73B | $7.18B | $6.54B |
| Net Income Avg | $6.98B | $7.39B | $7.31B | $7.19B | $7.60B | $7.86B | $8.14B | $7.44B |
| Low | $6.63B | $7.22B | $7.20B | $7.09B | $7.49B | $7.74B | $8.02B | $7.33B |
| High | $7.10B | $7.64B | $7.45B | $7.33B | $7.75B | $8.01B | $8.30B | $7.59B |
| EPS Avg | $2.85 | $3.02 | $2.99 | $2.94 | $3.11 | $3.21 | $3.33 | $3.04 |
| Low | $2.71 | $2.95 | $2.94 | $2.90 | $3.06 | $3.16 | $3.28 | $3.00 |
| High | $2.90 | $3.12 | $3.05 | $3.00 | $3.17 | $3.27 | $3.39 | $3.10 |
| Analysts (Rev / EPS) | 11 / 11 | 11 / 12 | 10 / 8 | 5 / 5 | 5 / 5 | 8 / 5 | 5 / 5 | 4 / 6 |